KRISTINA DEVEAU: Open Payments
NPI 1528511482 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$840 in 41 payments from 13 companies in 2025. Trend: 2023 $490 · 2024 $1,064 · 2025 $840
Food & beverage: $840
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $186 |
| Novo Nordisk Inc | 14 | $176 |
| Astellas Pharma US Inc | 6 | $150 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| Abbott Laboratories | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| ABBVIE INC. | 1 | $29 |
| Corcept Therapeutics | 1 | $29 |
| Eisai Inc. | 1 | $26 |
| SANOFI PASTEUR INC. | 1 | $23 |
Products named: AIRSUPRA, Veozah, Ozempic, Wegovy, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, JARDIANCE, AVYCAZ.
Industry payments across AZ — which companies pay providers there.
